Skip to main navigation Skip to search Skip to main content

Refractory metastatic colorectal cancer Advisory board on “Trifluridine/tipiracil + Bevacizumab combination

Activity: Consultancy types › Work on advisory panel to industry or government or non-government organisation

Description

Advisor for Servier to implement this new combination for colorectal cancer patients
Period11 Jul 2023
Work forServier Pharmaceutical Co. Ltd, France
Degree of RecognitionInternational